Reference
Villa-Zapata L, et al. A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS) Drug Safety : 18 Jul 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01200-4
Rights and permissions
About this article
Cite this article
Drug interaction safety signals for tizanidine identified. Reactions Weekly 1916, 9 (2022). https://doi.org/10.1007/s40278-022-19468-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-19468-y